Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 208

Similar articles for PubMed (Select 17134581)

1.

Clinical outcomes after autologous haematopoietic stem cell transplantation in patients with progressive multiple sclerosis.

Xu J, Ji BX, Su L, Dong HQ, Sun XJ, Liu CY.

Chin Med J (Engl). 2006 Nov 20;119(22):1851-5.

PMID:
17134581
2.

Clinical outcome of autologous peripheral blood stem cell transplantation in opticospinal and conventional forms of secondary progressive multiple sclerosis in a Chinese population.

Xu J, Ji BX, Su L, Dong HQ, Sun WL, Wan SG, Liu YO, Zhang P, Liu CY.

Ann Hematol. 2011 Mar;90(3):343-8. doi: 10.1007/s00277-010-1071-5. Epub 2010 Sep 25.

PMID:
20872003
3.

Autologous peripheral blood stem cell transplantation for severe multiple sclerosis.

Su L, Xu J, Ji BX, Wan SG, Lu CY, Dong HQ, Yu YY, Lu DP.

Int J Hematol. 2006 Oct;84(3):276-81.

PMID:
17050205
4.

High-dose immunoablation with autologous haematopoietic stem cell transplantation in aggressive multiple sclerosis: a single centre 10-year experience.

Krasulová E, Trneny M, Kozák T, Vacková B, Pohlreich D, Kemlink D, Kobylka P, Kovárová I, Lhotáková P, Havrdová E.

Mult Scler. 2010 Jun;16(6):685-93. doi: 10.1177/1352458510364538. Epub 2010 Mar 29.

PMID:
20350962
5.

CD34+ selected autologous peripheral blood stem cell transplantation for multiple sclerosis: report of toxicity and treatment results at one year of follow-up in 15 patients.

Carreras E, Saiz A, Marín P, Martínez C, Rovira M, Villamor N, Aymerich M, Lozano M, Fernández-Avilés F, Urbano-Izpizua A, Montserrat E, Graus F.

Haematologica. 2003 Mar;88(3):306-14.

6.

Hematopoietic stem cell transplantation for multiple sclerosis. A retrospective multicenter study.

Fassas A, Passweg JR, Anagnostopoulos A, Kazis A, Kozak T, Havrdova E, Carreras E, Graus F, Kashyap A, Openshaw H, Schipperus M, Deconinck E, Mancardi G, Marmont A, Hansz J, Rabusin M, Zuazu Nagore FJ, Besalduch J, Dentamaro T, Fouillard L, Hertenstein B, La Nasa G, Musso M, Papineschi F, Rowe JM, Saccardi R, Steck A, Kappos L, Gratwohl A, Tyndall A, Samijn J; Autoimmune Disease Working Party of the EBMT (European Group for Blood and Marrow Transplantation).

J Neurol. 2002 Aug;249(8):1088-97. Erratum in: J Neurol. 2002 Oct;249(10):1482.. J Neurol. 2002 Nov;249(11):1619.. Samign, J [corrected to Samijn, J].

PMID:
12195460
7.

High-dose immunosuppressive therapy with autologous hematopoietic stem cell transplantation as a treatment option in multiple sclerosis.

Shevchenko YL, Novik AA, Kuznetsov AN, Afanasiev BV, Lisukov IA, Kozlov VA, Rykavicin OA, Ionova TI, Melnichenko VY, Fedorenko DA, Kulagin AD, Shamanski SV, Ivanov RA, Gorodokin G.

Exp Hematol. 2008 Aug;36(8):922-8. doi: 10.1016/j.exphem.2008.03.001. Epub 2008 May 12.

PMID:
18468768
8.

Autologous hematopoietic stem cell transplantation suppresses Gd-enhanced MRI activity in MS.

Mancardi GL, Saccardi R, Filippi M, Gualandi F, Murialdo A, Inglese M, Marrosu MG, Meucci G, Massacesi L, Lugaresi A, Pagliai F, Sormani MP, Sardanelli F, Marmont A; Italian GITMO-NEURO Intergroup on Autologous Hematopoietic Stem Cell Transplantation for Multiple Sclerosis.

Neurology. 2001 Jul 10;57(1):62-8.

PMID:
11445629
10.

Autologous HSCT for severe progressive multiple sclerosis in a multicenter trial: impact on disease activity and quality of life.

Saccardi R, Mancardi GL, Solari A, Bosi A, Bruzzi P, Di Bartolomeo P, Donelli A, Filippi M, Guerrasio A, Gualandi F, La Nasa G, Murialdo A, Pagliai F, Papineschi F, Scappini B, Marmont AM.

Blood. 2005 Mar 15;105(6):2601-7. Epub 2004 Nov 16.

11.

Complete remission status before autologous stem cell transplantation is an important prognostic factor in patients with multiple myeloma undergoing upfront single autologous transplantation.

Kim JS, Kim K, Cheong JW, Min YH, Suh C, Kim H, Jo DY, Ryoo HM, Yoon SS, Lee JH; Korean Multiple Myeloma Working Party.

Biol Blood Marrow Transplant. 2009 Apr;15(4):463-70. doi: 10.1016/j.bbmt.2008.12.512.

12.

Autologous stem cell transplantation after complete remission and first consolidation in acute myeloid leukemia patients aged 61-70 years: results of the prospective EORTC-GIMEMA AML-13 study.

Thomas X, Suciu S, Rio B, Leone G, Broccia G, Fillet G, Jehn U, Feremans W, Meloni G, Vignetti M, de Witte T, Amadori S.

Haematologica. 2007 Mar;92(3):389-96.

13.

Autologous haematopoietic stem cell transplantation with an intermediate intensity conditioning regimen in multiple sclerosis: the Italian multi-centre experience.

Mancardi GL, Sormani MP, Di Gioia M, Vuolo L, Gualandi F, Amato MP, Capello E, Currò D, Uccelli A, Bertolotto A, Gasperini C, Lugaresi A, Merelli E, Meucci G, Motti L, Tola MR, Scarpini E, Repice AM, Massacesi L, Saccardi R; Italian BMT Study Group.

Mult Scler. 2012 Jun;18(6):835-42. doi: 10.1177/1352458511429320. Epub 2011 Nov 29.

PMID:
22127896
14.

Long-term outcome of autologous stem cell transplantation in light chain deposition disease.

Lorenz EC, Gertz MA, Fervenza FC, Dispenzieri A, Lacy MQ, Hayman SR, Gastineau DA, Leung N.

Nephrol Dial Transplant. 2008 Jun;23(6):2052-7. doi: 10.1093/ndt/gfm918. Epub 2008 Jan 4.

15.

Autologous stem cell transplantation for progressive multiple sclerosis: update of the European Group for Blood and Marrow Transplantation autoimmune diseases working party database.

Saccardi R, Kozak T, Bocelli-Tyndall C, Fassas A, Kazis A, Havrdova E, Carreras E, Saiz A, Löwenberg B, te Boekhorst PA, Gualandio F, Openshaw H, Longo G, Pagliai F, Massacesi L, Deconink E, Ouyang J, Nagore FJ, Besalduch J, Lisukov IA, Bonini A, Merelli E, Slavino S, Gratwohl A, Passweg J, Tyndall A, Steck AJ, Andolina M, Capobianco M, Martin JL, Lugaresi A, Meucci G, Sáez RA, Clark RE, Fernandez MN, Fouillard L, Herstenstein B, Koza V, Cocco E, Baurmann H, Mancardi GL; Autoimmune Diseases Working Party of EBMT.

Mult Scler. 2006 Dec;12(6):814-23.

PMID:
17263012
16.

High-dose immunosuppressive therapy with PBPC support in the treatment of poor risk multiple sclerosis.

Kozák T, Havrdová E, Pit'ha J, Gregora E, Pytlík R, Maaloufová J, Marecková H, Kobylka P, Vodvárková S.

Bone Marrow Transplant. 2000 Mar;25(5):525-31.

17.

Autologous hematopoietic stem cell transplantation in refractory celiac disease with aberrant T cells.

Al-toma A, Visser OJ, van Roessel HM, von Blomberg BM, Verbeek WH, Scholten PE, Ossenkoppele GJ, Huijgens PC, Mulder CJ.

Blood. 2007 Mar 1;109(5):2243-9. Epub 2006 Oct 26.

18.

T cell-depleted autologous hematopoietic stem cell transplantation for multiple sclerosis: report on the first three patients.

Burt RK, Traynor AE, Cohen B, Karlin KH, Davis FA, Stefoski D, Terry C, Lobeck L, Russell EJ, Goolsby C, Rosen S, Gordon LI, Keever-Taylor C, Brush M, Fishman M, Burns WH.

Bone Marrow Transplant. 1998 Mar;21(6):537-41.

19.

Autologous stem cell transplantation in children with severe progressive systemic or polyarticular juvenile idiopathic arthritis: long-term follow-up of a prospective clinical trial.

Brinkman DM, de Kleer IM, ten Cate R, van Rossum MA, Bekkering WP, Fasth A, van Tol MJ, Kuis W, Wulffraat NM, Vossen JM.

Arthritis Rheum. 2007 Jul;56(7):2410-21.

20.

Long-term efficacy of autologous haematopoietic stem cell transplantation in multiple sclerosis at a single institution in China.

Chen B, Zhou M, Ouyang J, Zhou R, Xu J, Zhang Q, Yang Y, Xu Y, Shao X, Meng L, Wang J, Xu Y, Ni X, Zhang X.

Neurol Sci. 2012 Aug;33(4):881-6. doi: 10.1007/s10072-011-0859-y. Epub 2011 Dec 8.

PMID:
22160751
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk